Conference Coverage

Heart disease in GPA exacts high toll in year 2 and beyond

Publish date: May 3, 2018

 

REPORTING FROM RHEUMATOLOGY 2018

Arthritis Research UK funded the trial. Dr. Pearce had nothing to disclose.

SOURCE: Pearce F et al. Rheumatology. 2018;57(Suppl. 3):key075.204.

Pages

Recommended Reading

Despite global decline, rheumatic heart disease persists in poorest regions
MDedge Cardiology
Riociguat may benefit subset of PAH patients
MDedge Cardiology
Health disparities in rural America: Chronic conditions
MDedge Cardiology
FDA: Gadolinium retention prompts new GBCA class warning, safety measures
MDedge Cardiology
FDA: Gadolinium retention prompts new GBCA class warning, safety measures
MDedge Cardiology
Large-vessel vasculitis: More severe in HIV-infected patients
MDedge Cardiology
Phosphodiesterase-5 inhibitors often prescribed inappropriately
MDedge Cardiology
Few acutely ill hospitalized patients receive VTE prophylaxis
MDedge Cardiology
MDedge Daily News: Which nonopioids are ripe for abuse?
MDedge Cardiology
MDedge Daily News: Lupus is quietly killing young women
MDedge Cardiology